Characterizing the Treatment Courses of Ranibizumab and Panretinal Photocoagulation for Retinopathy of Prematurity
Ranibizumab was initiated at a younger age with higher retreatment and reactivation events compared to PRP, underscoring variability in real-world ROP treatment patterns and outcomes.
Authors
- Alexander B Crane (ORCID: https://orcid.org/0000-0001-7291-7932)
- Marco A. Zarbin (ORCID: https://orcid.org/0000-0002-7811-7132)
- Neelakshi Bhagat (ORCID: https://orcid.org/0000-0003-2187-3145)
- Suqin Guo
- Rudolph S. Wagner
- Rita Vought
- Victoria Vought
Institutions
- Rutgers, The State University of New Jersey (US)
- NYU Langone Health (US)
- Rutgers New Jersey Medical School (US)
Publication Details
- Journal
- Journal of Pediatric Ophthalmology & Strabismus
- Published
- 2026-03-11
- DOI
- https://doi.org/10.3928/01913913-20251204-07
- Primary Topic
- Retinopathy of Prematurity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00